About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Colorado | 356 Studies

Clinical Trials LymphomaColorado

Lymphoma Clinical Trials in Colorado

Find 356 clinical trials for lymphoma near Colorado. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Colorado

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-356 of 356 trials

CompletedMobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma PatientsThe purpose of this study is to determine whether the combination of AMD3100 (plerixafor) and granulocyte colony-stimulating factor (G-CSF or generic name filgrastim) is better…NCT00103610·Phoenix, Arizona and 31 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedRituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00075946·Scottsdale, Arizona and 482 others

CompletedThe PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII BThe purpose of this study is to determine the safety and effectiveness of the SAPIEN XT™ THV with the associated delivery system for inoperable patients with severe symptomatic…NCT02184442·Little Rock, Arkansas and 52 others

CompletedRituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00274924·Palo Alto, California and 103 others

TerminatedTrial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's LymphomaThe purpose of this research study is to find out if treatment with rituximab in combination with aldesleukin (compared to rituximab alone) decreases the risk of cancer returning…NCT00250861·Denver, Colorado and 20 others

TerminatedA Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell LymphomaThis 2-arm study was designed to compare the efficacy and safety of bevacizumab (Avastin) in combination with rituximab (MabThera) and CHOP (cyclophosphamide, hydroxydaunorubicin…NCT00486759·La Jolla, California and 265 others

CompletedA Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 ExpressionThis clinical trial will study brentuximab vedotin with CHP to find out if the drugs work for people who have certain types of peripheral T-cell lymphoma (PTCL).NCT04569032·Birmingham, Alabama and 62 others

RecruitingEvaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHLThis Phase II trial evaluates the optimization of the cytokine release syndrome (CRS) proﬁle for gloﬁtamab in combination with gemcitabine and oxaliplatin (Gloﬁt-GemOx) followed…NCT06806033·Anchorage, Alaska and 52 others

CompletedA Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesThis phase I multicenter feasibility trial is studying the safety and potential efficacy of infusing ex vivo expanded cord blood progenitors with one unmanipulated umbilical cord…NCT00343798·Duarte, California and 3 others

CompletedDonor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerThis phase II trial is studying how well umbilical cord blood transplant from a donor works in treating patients with hematological cancer.NCT00723099·Aurora, Colorado and 5 others

CompletedClinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell LymphomaThe Valchlor PROVe study is a multi-center, prospective, observational, US-based drug study that longitudinally follows patients with Mycosis Fungoides Cutaneous T-cell Lymphoma…NCT02296164·Little Rock, Arkansas and 35 others

TerminatedA Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell LymphomaThis is a prospective, open-label, multi-center clinical study designed to evaluate the safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics, and immunogenicity of…NCT05972720·Little Rock, Arkansas and 30 others

TerminatedStudy Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.This study treats patients with diffuse large B-cell lymphoma whose disease is in complete remission due to previous treatment with Cyclophosphamide Doxorubicin hydrochloride…NCT00322218·Mesa, Arizona and 89 others

RecruitingTagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesTagraxofusp is a protein-drug conjugate consisting of a diphtheria toxin redirected to target CD123 has been approved for treatment in pediatric and adult patients with blastic…NCT05476770·Los Angeles, California and 30 others

RecruitingA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other…NCT01351545·Birmingham, Alabama and 141 others

CompletedA Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin LymphomaThis is an open-label, multicenter, phase 2 clinical trial to evaluate the efficacy and safety of brentuximab vedotin as a single agent in patients with CD30-positive non-Hodgkin…NCT01421667·Birmingham, Alabama and 33 others

PreviousPage 18 of 18

Other Conditions in Colorado

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia